Concepedia

Jaebong Jang

JJ

29

Publications

2.8K

Citations

21

H-Index

2011

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Seoul National University

Korea University

Kyungpook National University

Jaebong Jang is an author at Dana-Farber Cancer Institute specializing in medicine, molecular biology, and natural sciences.

Top concepts

MedicineMolecular BiologyDrug DiscoveryNatural SciencesPharmacologyCell BiologyRadiation OncologyVirologySmall MoleculesSignal Transduction

Publications per year

2011–2023

29

Publications

29

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Yong Jia, Cai‐Hong Yun, Eunyoung Park et al. · Nature · 2016 · 851 citations · Full text

Molecular Pharmacology, Medicine, Pharmacology +4

A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader

Hai‐Tsang Huang, Dennis Dobrovolsky, Joshiawa Paulk et al. · Cell chemical biology · 2017 · 431 citations · Full text

Protein Function, Chemoproteomic Approach, Structural Bioinformatics +13

Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor

Ciric To, Jaebong Jang, Ting Chen et al. · Cancer Discovery · 2019 · 319 citations · Full text

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Ciric To, Tyler S. Beyett, Jaebong Jang et al. · Nature Cancer · 2022 · 146 citations · Full text

Therapy-resistant Mutant Forms, Medicine, Pharmacology +9

Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations

Jaebong Jang, Ciric To, Dries J.H. De Clercq et al. · Angewandte Chemie International Edition · 2020 · 133 citations · Full text

Rows per page

1–5 of 29